Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trasylol in elective spinal fusion surgery
NCT00327379Phase 3Terminated
- Sponsor
- Bayer
- Start
- Feb 2006
- Primary completion
- Mar 2007
- Countries
- 3
01
Overview
A Phase 3 trial of aprotinin in postoperative hemorrhage, sponsored by Bayer. Started Feb 2006; status: terminated.
02
Drugs
aprotinin
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT00327379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327379.